# UARK 2006-15: A Study of Tandem Transplants With or Without Bortezomib and Thalidomide

> **NCT00574080** · PHASE3 · TERMINATED · sponsor: **University of Arkansas** · enrollment: 20 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Interim/Maintenance Dexamethasone
- **DRUG:** Induction/Consolidation Dexamethasone
- **DRUG:** Induction/Consolidation Cisplatin
- **DRUG:** Induction/Consolidation Adriamycin
- **DRUG:** InductionConsolidation Cyclophosphamide
- **DRUG:** Induction/Consolidation Etoposide
- **DRUG:** Induction Pegfilgrastim
- **DRUG:** Transplant 1 Dexamethasone
- **DRUG:** Transplant 1 Cisplatin
- **DRUG:** Transplant 1 Adriamycin
- **DRUG:** Transplant 1 Cyclophosphamide
- **DRUG:** Transplant 1 Etoposide
- **DRUG:** Transplant 1 Melphalan
- **DRUG:** Transplant 1 and 2 Pegfilgrastim
- **PROCEDURE:** Autologous Peripheral Blood Stem Cell Transplant (ASCT)
- **DRUG:** Transplant 2 Carmustine
- **DRUG:** Transplant 2 Etoposide
- **DRUG:** Transplant 2 Cytarabine
- **DRUG:** Transplant 2 Melphalan
- **DRUG:** Transplant 2 Dexamethasone

## Key facts

- **NCT ID:** NCT00574080
- **Lead sponsor:** University of Arkansas
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-07
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 20 (ACTUAL)
- **Why stopped:** low accrual
- **Last updated:** 2017-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00574080

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00574080, "UARK 2006-15: A Study of Tandem Transplants With or Without Bortezomib and Thalidomide". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00574080. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*